Literature DB >> 21138764

Specificity, location and function of βTrCP isoforms and their splice variants.

Joyce Putters1, Johan A Slotman, Jan P Gerlach, Ger J Strous.   

Abstract

SCF(βTrCP) is the ubiquitin ligase for a wide variety of substrates and functions in many cellular processes. βTrCP, the substrate binding factor of the SCF complex, has two isoforms, produced from different genes, and several splice variants. Despite a certain level of redundancy, knock-out studies show different phenotypes indicating different preferential substrates for the two isoforms. However, until now functional differences between βTrCP1 and 2 were not studied at the endogenous protein level. We generated isoform-specific antibodies against βTrCP to characterise endogenous βTrCP isoforms and splice variants. We show that endogenous βTrCP1 and 2 localise to both nucleus and cytosol. Interestingly, we find that one splice variant of βTrCP2 localises exclusively to the nucleus and another only to the cytosol. In addition, we show that the substrate binding domain of βTrCP is the dominant localisation determinant.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21138764     DOI: 10.1016/j.cellsig.2010.11.015

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  9 in total

1.  Two major alternative splice variants of beta-TrCP1 interact with CENP-W with different binding preferences.

Authors:  Yeongmi Cheon; Soojin Lee
Journal:  Genes Genomics       Date:  2018-09-28       Impact factor: 1.839

2.  The β-TrCP-Mediated Pathway Cooperates with the Keap1-Mediated Pathway in Nrf2 Degradation In Vivo.

Authors:  Ayumi Kuga; Kouhei Tsuchida; Harit Panda; Makoto Horiuchi; Akihito Otsuki; Keiko Taguchi; Fumiki Katsuoka; Mikiko Suzuki; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2022-06-08       Impact factor: 5.069

3.  Isoform-specific SCF(Fbw7) ubiquitination mediates differential regulation of PGC-1α.

Authors:  Julie S Trausch-Azar; Mona Abed; Amir Orian; Alan L Schwartz
Journal:  J Cell Physiol       Date:  2015-04       Impact factor: 6.384

Review 4.  Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease.

Authors:  Lauren E Tebay; Holly Robertson; Stephen T Durant; Steven R Vitale; Trevor M Penning; Albena T Dinkova-Kostova; John D Hayes
Journal:  Free Radic Biol Med       Date:  2015-06-27       Impact factor: 7.376

5.  A lowered 26S proteasome activity correlates with mantle lymphoma cell lines resistance to genotoxic stress.

Authors:  Khaoula Ben Younes; Simon Body; Élodie Costé; Pierre-Julien Viailly; Hadjer Miloudi; Clémence Coudre; Fabrice Jardin; Fatma Ben Aissa-Fennira; Brigitte Sola
Journal:  BMC Cancer       Date:  2017-08-10       Impact factor: 4.430

6.  Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity.

Authors:  S Chowdhry; Y Zhang; M McMahon; C Sutherland; A Cuadrado; J D Hayes
Journal:  Oncogene       Date:  2012-09-10       Impact factor: 9.867

7.  Protein Kinase R Degradation Is Essential for Rift Valley Fever Virus Infection and Is Regulated by SKP1-CUL1-F-box (SCF)FBXW11-NSs E3 Ligase.

Authors:  Rajini Mudhasani; Julie P Tran; Cary Retterer; Krishna P Kota; Chris A Whitehouse; Sina Bavari
Journal:  PLoS Pathog       Date:  2016-02-02       Impact factor: 6.823

8.  A design principle underlying the paradoxical roles of E3 ubiquitin ligases.

Authors:  Daewon Lee; Minjin Kim; Kwang-Hyun Cho
Journal:  Sci Rep       Date:  2014-07-04       Impact factor: 4.379

9.  WBP2 promotes BTRC mRNA stability to drive migration and invasion in triple-negative breast cancer via NF-κB activation.

Authors:  Yvonne Xinyi Lim; Hexian Lin; Tinghine Chu; Yoon Pin Lim
Journal:  Mol Oncol       Date:  2021-08-12       Impact factor: 6.603

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.